April 10th, 2026
We are incredibly proud to share that Vielight itPBM technology has been selected by the University of Utah’s Neurology department for a landmark $4.6M TBI research grant from the U.S. Department of War.
Vielight (itPBM) technology is the exclusive intervention for this definitive n=300 clinical trial, following powerful neuroprotection research by the U of Utah with NCAA Division I football players. In that breakthrough study, brain imaging data implied that our technology triggers significant neuroprotection and resilience effects – results that only Vielight itPBM tech has been able to achieve.
This project follows our powerful neuroprotection research with NCAA Division I football players. In that breakthrough study, brain imaging data implied that our technology triggers significant neuroprotection and resilience effects – results that only Vielight itPBM tech has been able to achieve.
The Problem: For our military and first responders, TBI is an invisible but devastating reality. Chronic mTBI often leads to years of cognitive decline and a diminished quality of life. Current treatments are frequently limited to symptom management, leaving a massive gap in actual neurological recovery.
The Opportunity: This grant represents a relatively small investment in a technology that could yield massive results. By validating a non-invasive, drug-free solution, we aren’t just looking for a treatment – we are looking for a scalable way to restore brain health, improve lives, and potentially save the healthcare system billions in long-term care costs.
Led by Dr. Elisabeth Wilde and Dr. Carrie Esopenko, this research will use advanced MRI to prove that Vielight technology can provide the protection and resilience our heroes deserve.
We are honored that our technology is the clinical foundation for this mission.